Both in Lab Analytical Instruments
908 Devices vs Cytek Biosciences
Over the past year MASS returned +38.0% and CTKB returned +54.1%; their daily moves had a correlation of 0.22.
MASS +38.0% CTKB +54.1%Growth of $1, one year, split-adjusted
| Metric | MASS | CTKB |
|---|---|---|
| Price | $10.95 | $6.07 |
| Market cap | $452.4M | $789.0M |
| Today | +2.58% | +1.85% |
| 1 month | −11.2% | +12.8% |
| 6 months | +35.8% | +22.9% |
| Year to date | +108.5% | +20.2% |
| 1 year | +38.0% | +54.1% |
| Revenue growth (YoY) | +23.3% | +5.6% |
| Gross margin | 51.9% | 58.9% |
| Net margin | −74.0% | −25.3% |
| P/E (TTM) | — | — |
| Price / sales | 7.4× | 3.8× |
| Net cash | $101.5M | $261.8M |
| Dividend yield | — | — |
| Volatility (60d) | 59.5% | 50.4% |
| Short % of float | 8.7% | 3.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).